U.K. science academy partners with investment fund

05/7/2013 | Financial Times (tiered subscription model)

Fellows at the U.K.'s Academy of Medical Sciences will advise investors at Park Vale Capital's F2 Bioscience IV fund, which will invest in drugs and medical devices in late-stage clinical trials. The academy will receive an annual retainer and a portion of the profits.

View Full Article in:

Financial Times (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA